Table 3.

Assessment of high-resolution computed tomography of the lung and pulmonary function test findings in the subjects with humoral immunodeficiency by diagnosis groups

	CVID		Hyper IgM		XLA		Selective IgA deficiency		IgG subgroup deficiency		Total
	n	%	n	%	n	%	n	%	n	%	n	%
Lung HRCT
Ground-glass opacity	7	30.4	2	40	0	0	0	0	0	0	9	16.6
Atelectasis	11	47.8	2	40	1	33.3	0	0	1	5	15	27.7
Bronchiectasis	11	47.8	3	60	1	33.3	0	0	0	0	15	27.7
Consolidation	2	8.6	2	40	0	0	0	0	0	0	4	7.4
Bronchial wall thickness	3	13	0	0	0	0	0	0	0	0	3	5.5
Parenchymal nodule	3	13	2	40	0	0	0	0	0	0	5	9.2
Pleural effusion	1	4.3	0	0	0	0	0	0	0	0	1	1.8
Tree in bud	4	17.3	0	0	0	0	0	0	0	0	4	7.4
Fibrosis	1	4.3	1	20	0	0	0	0	0	0	2	3.7
Emphysema	0	0	0	0	1	33.3	0	0	0	0	1	1.8
Hilar LAP	6	26	2	40	0	0	1	25	2	10	11	20.3
Mediastinal LAP	5	21.7	0	0	0	0	0	0	1	5	6	11.1
Total	23	100	5	100	3	100	4	100	19	100	54	100
Pulmonary function tests
Normal	7	31.8	2	40	1	33.3	3	100	15	100	28	58.3
Mild obstructive	2	9.0	0	0	0	0	0	0	0	0	2	4.1
Moderate obstructive	2	9.0	0	0	0	0	0	0	0	0	3	6.2
Marked obstructive	2	9.0	0	0	0	0	0	0	0	0	3	6.2
Mild restrictive	3	13.6	0	0	0	0	0	0	0	0	3	6.2
Moderate restrictive	2	5.3	1	20	0	0	0	0	0	0	2	4.1
Mild obstructive+restrictive	0	0	0	0	0	0	0	0	0	0	1	2.0
Moderate obstructive +restrictive	4	18	2	40	1	33.3	0	0	0	0	6	12.5
Total (Number of subjects who underwent pulmonary function test)	22	100	5	100	3	100	3	100	15	100	48	100

Hyper IgM: Hyperimmunoglobulin M syndrome; HRCT: High-resolution computed tomography; CVID: Common variable immunodeficiency; XLA: X-linked agammaglobulinemia; LAP: Lymphadenopathy